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A rat IgM monoclonal antibody, PA3-795, inhibits the antigen-specific responses of mouse
T-cell hybridomas. It recognizes a heavily glycosylated cell-surface protein, designated
Lgp55, that is detectable after activation on mature T cells. During fetal life, Lgp55 is found
at high levels on newly immigrant thymic T-cell precursors prior to surface expression of
other T-lineage molecules. High levels of expression are also found on thymocytes in the
outer cortex of adult mice. Thymocytes at later stages of differentiation bear decreasing
amounts of surface Lgp55, and none is detectable on "single-positive" thymocytes in the
thymic medulla or on resting mature T cells from the periphery. Addition of monoclonal
anti-Lgp55 to fetal thymus organ culture decreases the output of "mature" CD4 single-
positive thymocytes when it is begun before fetal day 13.5. These findings suggest that
Lgp55 contributes to cell-cell interactions that regulate very early steps in T-cell develop-
ment in the mouse.
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INTRODUCTION
Undetectable on resting peripheral mouse T cells,
Lgp55 is expressed at high levels on activated T cells
(both CD4 and CD8) and most T-cell hybridomas.
Binding by monoclonal anti-Lgp55 (PA3-795) inhib-
its low-affinity responses of T-cell hybridomas to
antigen presented by B-cell lymphomas (Glode
et al., 1990). Anti-Lgp55 also inhibits proliferation
and the generation of cytotoxic lymphocytes (CTL)
in primary mixed-lymphocyte reactions in vitro
(Golde et al., 1990; M. McDuffie and R. Gill, unpub-
lished data). Thus, the functional evidence to date
indicates a role in the immune response similar to
that of the adhesion molecule LFA-1 and its ligands
(Davignon et al., 1981; Boyd et al., 1988). Like ma-
ture T cells after activation, most adult thymocytes
(> 50%) express Lgp55 at moderate to high levels
(Golde et al., 1990). This finding raised the possibil-
ity that Lgp55 might enhance interactions between
T-cell precursors and the thymic stromal cells that
direct the developmental sequence.
"Corresponding author.
During murine fetal development, lymphoid pre-
cursors from yolk sac and fetal liver begin to
colonize the murine epithelial thymus structure on
days 11 and 12 of the 19- to 21-day gestation. On
day 12, the thymus is well-colonized with relatively
quiescent lymphoid precursors. By day 14 of gesta-
tion, these lymphoid precursors are actively prolif-
erating, and the T-cell marker Thy-1 has appeared
on a minority of thymocytes (Fig. 2; Ceredig et al.,
1983). In addition, the earliest rearrangements of
T-cell receptor genes have occurred (Born et al.,
1986) and IL-2 message is detectable (Pardoll et al.,
1987). By day 15, mature T cells of the ,c type have
developed, Thy-1 is expressed on the majority of
lymphoid cells, and the differentiation of the first c,8
T cells, which will appear on day 18, is well
underway. The signals that initiate T-cell develop-
ment on day 13 have not been determined, but
these steps do not occur to any significant degree in
the absence of a functional thymic epithelium
(Maryanski et al., 1981).
To determine the developmental stage in which
Lgp55 might participate, thymocytes from fetal mice
were first examined for expression of Lgp55 in
relation to other markers of thymocyte differentia-
tion. Because LFA-1 plays a role similar to Lgp55 on
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mature T cells and is also expressed on the majority
of thymocytes in the adult mouse (Golde et al.,
1990), its expression was examined along with that
of Lgp55. Detection of high levels of Lgp55 on early
thymic presursors, in advance of other T-cell
markers, prompted and exploration of the possible
role of this accessory molecule in T-cell differentia-
tion.
RESULTS
Both LFA-1 and Lgp55 were coexpressed on most
thymocytes from fetal mice at day 15 of gestation
(data not shown). However, the thymocyte precur-
sors found at day 13 expressed only Lgp55 (Fig. 1,
panel A). LFA-1 expression first appears on a sig-
nificant proportion of Lgp55
/ thymocytes between
days 13 and 14 of fetal development. During the
transition from day 14 through day 16, increasing
percentages of thymocytes coexpress Lgp55 and
LFA-1 (Fig. 1, panels B-D). This period coincides
with rearrangement of all T-cell receptor genes,
ending with rearrangement of the o-chain gene and
the first appearance of functional o,8 T-cell receptor
molecules on the surface of the developing thymo-
cytes. From the end of day 16 to adulthood, an
increasing percentage of the thymocytes displays
the LFA-lhigh/Lgp55
lw-mderate phenotype, reach-
ing 85% in the adult (Fig. 1, panel E). This subpop-
ulation of thymocytes must be largely coincident
with, if not identical to, the bulk of nonmature
CD4+/CD8
/ "double-positive" cells that also com-
prise 85% of the cells in the adult murine thymus
and serves as an intermediate step in the production
of o,8 T cells. Simultaneously, the fraction of
LFA-1-/Lgp55high cells falls from > 90% early on
day 14 to 1% in the adult:
Like LFA-1, early markers of precursor commit-
ment to T-cell lineages, such as Thy-1 and the
low-affinity p55 IL-2 receptor (IL-2R) are also ex-
pressed on the Lgp55
/ thymocyte subpopulation.
Figure 2, panel A, shows the progression of in-
creased expression of Thy-1 from day 14 to 17 of
fetal development: Virtually all Thy-1
/ cells in the
day-14 fetal thymus coexpress moderate to high
levels of Lgp55. Two-color immunofluorescence
confirms that these cells also bear LFA-1 (data not
shown). The IL-2R
/ cells previously described by
others as forming a significant subpopulation among
thymocytes during these stages of maturation
(Ceredig egal., 1985; Raulet, 1985; Shimonkevitz
Lgp55 LFA-1 Lgp55 vs. LFA-1
.,,’! 0.6%
A. EARLY DAY 13
0.6%
!..... +_---1 7.8%
,,
] ..i.T
RED only GREEN only
ADULT
RED vs. GREEN
FIGURE 1. Fetal C57BL/6J mice from timed pregnancies were
removed on the indicated day of gestation, and thymocyte
suspensions from one litter for each gestational age or from a
single adult were analyzed for expression of Lgp55 and LFA-1.
Lgp55 was detected using biotinylated PA3 antibody (mono-
clonal rat IgM); Streptavidin-phycoerythrin (PE-SA); LFA-1, us-
ing monoclonal rat IgG I21/7.7 as culture supernatant; and a
fluorescein-conjugated goat anti-rat IgG Fc (FITC-GAR Fc) that
does not cross-react with IgM. Ten thousand cells were counted
for samples from day 14; 2.5 x 104 for day 16; and 4.0 x 104 for
adult. Data shown are representative of three separate experi-
ments.
et al., 1987) also express Thy-1, and, by inference,
Lgp55 (Fig. 2, panel B) and LFA-1. In four separate
experiments, Thy-1
/ cells harvested from early day-
14 fetal thymus lobes ranged from 4 to 22% of the
nucleated cells; IL-2R
/ cells, from 3 to 9%.
Monoclonal antibody staining of frozen sections
from adult thymus confirmed the impression, based
on flow cytometric analyses, that Lgp55 is expressed
only on cortical thymocytes, whereas LFA-1 is
present on thmocytes found in both cortex and
medulla (data not shown). Absolute lack of staining
by anti-Lgp55 on medullary thymocytes indicates
that cells at this developmental stage are similar toLGP55 IN THYMOCYTE DIFFERENTIATION 259
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FIGURE 2. Samples for cytofluorographic analysis were prepared and analyzed as described for Fig. 1. Lgp55 was detected using
PA3 culture supernatant and fluorescein-conjugated RG7/9.1; low-affinity IL-2 receptors (p55) with monoclonal rat PC61 supernatant
and FITC-GAR Fc; Thy-1, using biotinylated T24/40.7 0 and PE-SA. For each primary antibody (PA3 or PC61), free binding sites on
the secondary antibodies were blocked by a second incubation with supernatant containing the primary antibody prior to exposure
to biotinylated anti-Thy-1. Results were confirmed using biotinylated PA3 and either T24/40.7 or PC61 supernatant in the same
protocol as described in the legend to Fig. for anti-LFA-1. Samples of -> 104 cells were analyzed for each histogram. Data shown are
representative of four separate experiments.
peripheral T cells, on which no detectable Lgp55 is
expressed prior to activation.
The murine analog of human ICAM-1, shown by
direct binding studies to be a ligand of LFA-1, is
identified by the monoclonal antibody YN1/1.7.
This molecule is not found on thymocytes bearing
high levels of Lgp55 (Fig. 3A). ICAM-1 expression,
therefore, does not mark the earliest thymic precur-
sors and is unlikely to play a role in the earliest
stages of differentiation. It may, however, have an
impact on some subsets of thymocytes at later
developmental stages.
Following commitment to the T-cell lineage dur-
ing the first stage of thymocyte maturation, two
pathways of differentiation appear in the fetal thy-
mus by late day 16. Thy-1 cells bearing CD3 and
T-cell receptors have developed and represent 3 to
6% of thymocytes. Simultaneously, thymocytes that
have rearranged c and//T-cell receptor genes begin
to express CD8 molecules as they enter the phase of
T-cell differentiation during which developing
clones are "selected" for self-tolerance and restric-
tion to self-MHC. Figure 4 shows that both CD8 and
CD3 are expressed exclusively on Lgp55 thymo-
cytes at day 16 of fetal development. Whereas the
CD8 cells represent the major c,8 pathway of
thymocyte differentiation, the CD3 cells at this
stage are presumed to bear ,c T-cell receptors, as
they are unable to bind at T-cell receptor antibody,
H57-597, which binds to all ,8 chains (Fig. 4C).
Thus, both of the major pathways of thymic T-cell
development derive from Lgp55 precursors.
To determine the role of Lgp55 in T-cell develop-
ment, fetal thymus lobes from C57BL/6J mice were260 M. McDUFFIE and W.T. GOLDE
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FIGURE 3. Thymocytes, pooled from a litter of fetal mice at day
14 of gestation or from a single adult, were incubated with
biotinylated PA3, with or without ascites from the hybridoma
YN1/1.7, diluted 1/100 in balanced salt solution. FITC-GAR Fc
and PE-SA were used as secondary reagents. Ten thousand cells
from day 14 fetal thymuses were analyzed, and 4x103 adult
thymocytes.
cultured with anti-Lgp55 for periods of 2.5 to 6.5
days. Control cultures were treated with buffer
alone (phosphate-buffered saline, [PBS], pH 7.4) or
control antibodies. Table 1 summarizes three repre-
sentative experiments using thymus lobes from mice
at days 13 to 14 of gestational age cultured for 2.5 to
3 days. For these experiments, the control antibody
used was M5/114, a monoclonal rat IgG that rec-
ognizes the I-A
b molecule (Bhattacharya etal.,
1981). This antibody binds to thymocytes via pas-
sively acquired I-A molecules (Sharrow et al., 1981),
which may not be integrated normally into the cell
membranes. Treatment with anti-Lgp55 decreased
the cell numbers produced from test cultures com-
pared to controls when added to thymus lobes
harvested early on day 13 of gestation. Table 1
shows that thymus lobes from gestational ages of
< 13.5 days were consistently more susceptible to
the effects of anti-Lgp55 than those -> 13.5 days in
each individual experiment. Five additional experi-
ments using pooled thymus lobes from litters of
defined gestational ages confirmed these results for
culture periods of 3 to 6:5 days (data not shown).
Because interactions via c,8 T-cell receptors and
MHC Class II molecules clearly play a role in
survival of some thymocytes during the second
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FIGURE 4. Aliquots of the thymocytes from the day-16 litter
shown in Fig. were analyzed for expression of CD8, CD3, and
T-cell receptor c]/using a staining protocol (with blocking for
anti-CD3 and anti-c,8) as described in the legend for Fig. 2.
Lgp55:biotinylated-PA3 with PE-SA; CD8: monoclonal 53-6.72
as supernatant and FITC-GAR Fc; CD3: monoclonal 145-2Cll
and fluorescein-conjugated goat anti-mouse Ig that cross-reacts
with rat Ig light chains (FITC-GAM); T-cell receptor ]/: mono-
clonal H57-597 and FITC-GAM.
stage of T-cell development (days 4 to 6 of fetal
thymus organ culture), the control cultures for ex-
periments using culture periods of > 4.5 days con-
tained either PBS alone or a rat monoclonal anti-
TCR idiotype (KJ1-26; Haskins etal., 1983) that
binds to an undetectable number of cells in these
thymus lobes.
Most importantly, anti-Lgp55 antibody treatment
also reduces the number of phenotypically mature
CD4/8 in fetal thymus organ culture. Table 2LGP55 IN THYMOCYTE DIFFERENTIATION 261
Experiment
TABLE
Cell Yield Is Decreased in Anti-Lgp55-Treated Fetal Thymus Organ Culture
Fetal age Culture Treatment Viable lymph.
(days) (days) x 103/lobe)
% of control
13 3 Anti-Ia 40.0
Anti-Lgp55 0
b 0
14 3 Anti-Ia 54.9
Anti-Lgp55 27.3 50
13 3 Anti-Ia 31.9
Anti-Lgp55 1.5 5
13.5 3 Anti-Ia 70.1
Anti-Lgp55 17.0 24
14 3 Anti-Ia 49.2
Anti-Lgp55 33.1 67
14 3 Anti-Ia 74.4
Anti-Lgp55 17.0 23
13 3 Anti-Ia 29.0
Anti-Lgp55 12.7 44
13.5 3 Anti-Ia 61.1
Anti-Lgp55 60.9 100
13 3 None 9.2
None 9.6
Anti-Ia 10.6 113
aLobes from single litters, dated by vaginal plug and by thymus morphology at the time of sacrifice, divided equally between control and experimental culture wells.
bNo viable lymphoblasts detected.
CPooled thymus lobes from three litters.
TABLE 2
Anti-Lp55 Decreases Production of Mature T Cells
Expt. Fetal Treatment Days CD4//8- CD4//8 CD4-/8
age of culture (X 104/lobe) (X 104/lobe) (X 10 lobe)
13 No Ab 6 1.1 3.88 1.2
Anti-Lgp55 6 0.15 0.7 0.4
2 13 No Ab 6 2.5 7.7 8.9
No Ab 6 1.7 9.4 11.5
Anti-Lgp55 6 0.5 5.1 7.5
Anti-Lgp55 6 0.7 5.8 7.4
3 14 No Ab 7 2.7 18.0 3.1
Anti-Lgp55 7 1.1 9.2 2.4
shows the results of three experiments in which this
was examined. In all experiments, these cells were
decreased in number along with the total numbers
of "immature" double-positives (CD4//8/) and the
mixed population of CD4-/8/, which consists of
both double-positive precursors and mature cells.
DISCUSSION
Thymic T-cell differentiation is an example of on-
going organogenesis in the mature mammal. In the
thymic cortex, undifferentiated precursor cells from
bone marrow proliferate and acquire surface expres-
sion of the interactive molecules necessary for
mature T-cell function. Subsequent steps in dif-
ferentiation lead to the selection of a self-
restricted, largely self-tolerant T-cell repertoire.
Cell-cell interactions mediated by receptor/ligand
binding are known to play an integral role in the
second or "selection" phase of T-cell differentiation
in the thymus. For example, the "accessory" mole-
cules CD4 and CD8, which bind to MHC molecules,
participate in the process of clonal deletion that
eliminates self-reactive T cells during the final stages
of thymocyte differentiation (Kappler et al., 1987;
Smith, 1987; Fowlkes et al., 1988; McCarthy et al.,
1988).
Fine and Kruisbeek (1991) have suggested that
ICAM-1 influences thymocyte differentiation. In
their experiments, exposure to anti-ICAM-1 was
shown to decrease the numbers of CD4+/8 thymo-
cytes during the early days of fetal thymus organ
culture (days 3 and 4, after harvest at day 13 or 14262 M. McDUFFIE and W.T. GOLDE
of fetal development). However, despite the tran-
sient decrease in "double-positive" cells, differenti-
ation of CD4-8 and CD4/8 cells was not impaired.
These authors also attempted to use PA3-795 for
phenotypic analysis of thymocytes. Their antibody
preparation did not bind to either fetal or adult
thymocytes and, not surprisingly, did not influence
thymocyte differentiation in fetal thymus organ
culture. They attempted to isolate antibody from
ascites using ammonium sulfate precipitation and
column sizing appropriate for purifying IgG mole-
cules. Because the PA3 antibody is a pentameric IgM
that has no measurable affinity for Lgp55 in the
reduced state (M. McDuffie, unpublished data), it is
probable that the protein preparations used in this
study contained no antibody molecules capable of
binding the Lgp55 antigen.
Using our antibody preparations, Lgp55 can be
detected at the highest levels on day-13 thymocytes.
When day-13 fetal thymus lobes were exposed to
antibodies inhibiting Lgp55 function, cell numbers
in treated cultures were decreased from those in
control cultures, whether the controls were un-
treated or bathed in medium containing an irrele-
vant rat antibody. Similar cultures of day 13.5 to 14
thymus lobes, in which thymocytes had already
entered a committed phase of T-cell differentiation
marked by expression of Thy-1 and p55 IL-2R, were
more variably affected. These findings suggest that
Lpg55 accessory function enhances the earliest steps
of differentiation in the thymus, but is not required
for continued differentiation once the initial signal
has been transmitted. The lack of importance of
Lpg55 in later stages of T-cell development is mir-
rored by decreasing levels of surface expression as
the cells mature. Proliferation and differentiation
have not been shown to occur in the absence of
thymic stromal cells, so it is likely that the receptor
for this molecule will be found on the thymic
stromal cells that direct these steps.
Antibodies
PA3-795.4.16 (monoclonal rat IgM, anti-Lgp55) was
isolated from spleen cells of Sprague-Dawley rats,
immunized with the DBA/2-derived mastocytoma
P815, as previously described (Golde et al., 1990).
The other antibodies used for cytofluorographic
analyses were the following: I21/7.7 (rat mono-
clonal IgG, anti-LFA-1; I. Trowbridge), T24/40.7
(rat monoclonal IgG, anti-Thy-1; I. Trowbridge);
PC61 (rat monoclonal IgG, anti-IL-2 receptor; Hash-
imoto et al., 1986); YN1/1.7 (rat monoclonal IgG,
anti-ICAM-1; Prieto et al., 1989); 53-6.72 (rat mon-
oclonal IgG, anti-CD8; Ledbetter and Herzenberg,
1979); 145-2Cll (monoclonal hamster IgG, anti-
CD3a; Leo etal., 1987); H57-597 (hamster mono-
clonal IgG, anti-TCRafl; Kubo etal., 1989); and
RG7/9.1 (monoclonal mouse IgG, anti-rat IgG
kappa; L. Arnold). PA3-795.4.16 was isolated from
culture supernatant by crude ammonium sulfate
precipitation (50%), followed by dialysis in low
osmolarity buffer at pH 5.5. All other antibodies
were either used as culture supernatant or were
isolated from ascites using sequential ammonium
sulfate fractionation. Purified antibodies were stored
in the cold at a concentration ->5mg/ml in
phosphate-buffered saline at pH7.4 following filter
sterilization. Biotin and fluorescein conjugation were
performed by standard methods. Fluorescein-
conjugated goat anti-rat IgG Fc and goat anti-mouse
IgG antisera were obtained from Rockland, Inc.
(Gilbertsville, PA). Phycoerythrin-conjugated
Streptavidin was obtained from Fisher Biotech, Inc.
Flow Cytometry
Cell suspensions from thymus lobes were prepared
by teasing gently with needles and then analyzed
for phenotype on an EPICS C cytofluorograph as
previously described (McDuffie et al., 1988). Stain-
ing protocols are outlined in each figure legend.
MATERIALS AND METHODS
Mice
C57BL/6J mice were bred from stock obtained from
the Jackson Laboratory (Bar Harbor, ME). The day
of vaginal plugging was designated "day 0" of
gestation for fetal mice. Adults used for cytofluoro-
graph analyses were between 2 and 6 months of
age.
Fetal Thymus Organ Culture
Cultures were performed essentially as previously
described (Born et al., 1987). Briefly, thymus lobes
were washed free of maternal blood in cold Hank’s
balanced salt solution (BSS) and placed on 0.45-/m
Millipore filter strips supported by gelatin sponges.
Five to 14 lobes per well were cultured in six-well
tissue-culture plates with 3 ml of modified Mishell-
Dutton medium (Mishell and Dutton, 196 7) contain-LGP55 IN THYMOCYTE DIFFERENTIATION 263
ing 10% heat-inactivated fetal bovine serum to
avoid potential antibody-mediated complement ac-
tivation. Thymus lobes were bathed twice daily with
the medium containing PBS (untreated control) or
with medium containing antibody at 100/g/ml
were cultured for 3 or 6-7 days. Medium and
antibody were changed on day 3-4 for longer
culture periods.
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